These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

625 related items for PubMed ID: 11059757

  • 1. Down-regulation of X-linked inhibitor of apoptosis protein induces apoptosis in chemoresistant human ovarian cancer cells.
    Sasaki H, Sheng Y, Kotsuji F, Tsang BK.
    Cancer Res; 2000 Oct 15; 60(20):5659-66. PubMed ID: 11059757
    [Abstract] [Full Text] [Related]

  • 2. XIAP regulates Akt activity and caspase-3-dependent cleavage during cisplatin-induced apoptosis in human ovarian epithelial cancer cells.
    Asselin E, Mills GB, Tsang BK.
    Cancer Res; 2001 Mar 01; 61(5):1862-8. PubMed ID: 11280739
    [Abstract] [Full Text] [Related]

  • 3. Regulation of HtrA2/Omi by X-linked inhibitor of apoptosis protein in chemoresistance in human ovarian cancer cells.
    Yang X, Xing H, Gao Q, Chen G, Lu Y, Wang S, Ma D.
    Gynecol Oncol; 2005 May 01; 97(2):413-21. PubMed ID: 15863139
    [Abstract] [Full Text] [Related]

  • 4. Over-expression of PTEN sensitizes human ovarian cancer cells to cisplatin-induced apoptosis in a p53-dependent manner.
    Yan X, Fraser M, Qiu Q, Tsang BK.
    Gynecol Oncol; 2006 Aug 01; 102(2):348-55. PubMed ID: 16545436
    [Abstract] [Full Text] [Related]

  • 5. p53 is a determinant of X-linked inhibitor of apoptosis protein/Akt-mediated chemoresistance in human ovarian cancer cells.
    Fraser M, Leung BM, Yan X, Dan HC, Cheng JQ, Tsang BK.
    Cancer Res; 2003 Nov 01; 63(21):7081-8. PubMed ID: 14612499
    [Abstract] [Full Text] [Related]

  • 6. Mdm2 antagonists induce apoptosis and synergize with cisplatin overcoming chemoresistance in TP53 wild-type ovarian cancer cells.
    Mir R, Tortosa A, Martinez-Soler F, Vidal A, Condom E, Pérez-Perarnau A, Ruiz-Larroya T, Gil J, Giménez-Bonafé P.
    Int J Cancer; 2013 Apr 01; 132(7):1525-36. PubMed ID: 22961628
    [Abstract] [Full Text] [Related]

  • 7. Overexpression of HIPK2 circumvents the blockade of apoptosis in chemoresistant ovarian cancer cells.
    Puca R, Nardinocchi L, Pistritto G, D'Orazi G.
    Gynecol Oncol; 2008 Jun 01; 109(3):403-10. PubMed ID: 18395248
    [Abstract] [Full Text] [Related]

  • 8. Downregulation of LRRC8A protects human ovarian and alveolar carcinoma cells against Cisplatin-induced expression of p53, MDM2, p21Waf1/Cip1, and Caspase-9/-3 activation.
    Sørensen BH, Nielsen D, Thorsteinsdottir UA, Hoffmann EK, Lambert IH.
    Am J Physiol Cell Physiol; 2016 Jun 01; 310(11):C857-73. PubMed ID: 26984736
    [Abstract] [Full Text] [Related]

  • 9. Akt promotes cisplatin resistance in human ovarian cancer cells through inhibition of p53 phosphorylation and nuclear function.
    Fraser M, Bai T, Tsang BK.
    Int J Cancer; 2008 Feb 01; 122(3):534-46. PubMed ID: 17918180
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Human ovarian cancer and cisplatin resistance: possible role of inhibitor of apoptosis proteins.
    Li J, Feng Q, Kim JM, Schneiderman D, Liston P, Li M, Vanderhyden B, Faught W, Fung MF, Senterman M, Korneluk RG, Tsang BK.
    Endocrinology; 2001 Jan 01; 142(1):370-80. PubMed ID: 11145600
    [Abstract] [Full Text] [Related]

  • 12. Time-dependent changes in factors involved in the apoptotic process in human ovarian cancer cells as a response to cisplatin.
    Kolfschoten GM, Hulscher TM, Schrier SM, van Houten VM, Pinedo HM, Boven E.
    Gynecol Oncol; 2002 Mar 01; 84(3):404-12. PubMed ID: 11855878
    [Abstract] [Full Text] [Related]

  • 13. Sensitization of cis-platinum by a recombinant adenovirus vector expressing wild-type p53 gene in human ovarian carcinomas.
    Song K, Li Z, Seth P, Cowan KH, Sinha BK.
    Oncol Res; 1997 Mar 01; 9(11-12):603-9. PubMed ID: 9563008
    [Abstract] [Full Text] [Related]

  • 14. Caspase 3-mediated focal adhesion kinase processing in human ovarian cancer cells: possible regulation by X-linked inhibitor of apoptosis protein.
    Sasaki H, Kotsuji F, Tsang BK.
    Gynecol Oncol; 2002 May 01; 85(2):339-50. PubMed ID: 11972398
    [Abstract] [Full Text] [Related]

  • 15. Regulation of p53 and suppression of apoptosis by the soluble guanylyl cyclase/cGMP pathway in human ovarian cancer cells.
    Fraser M, Chan SL, Chan SS, Fiscus RR, Tsang BK.
    Oncogene; 2006 Apr 06; 25(15):2203-12. PubMed ID: 16288207
    [Abstract] [Full Text] [Related]

  • 16. Cisplatin resistance in an ovarian carcinoma is associated with a defect in programmed cell death control through XIAP regulation.
    Mansouri A, Zhang Q, Ridgway LD, Tian L, Claret FX.
    Oncol Res; 2003 Apr 06; 13(6-10):399-404. PubMed ID: 12725530
    [Abstract] [Full Text] [Related]

  • 17. Apoptosis and chemoresistance in human ovarian cancer: is Xiap a determinant?
    Li J, Sasaki H, Sheng YL, Schneiderman D, Xiao CW, Kotsuji F, Tsang BK.
    Biol Signals Recept; 2000 Apr 06; 9(2):122-30. PubMed ID: 10810207
    [Abstract] [Full Text] [Related]

  • 18. CD95-mediated apoptosis is impaired at receptor level by cellular FLICE-inhibitory protein (long form) in wild-type p53 human ovarian carcinoma.
    Mezzanzanica D, Balladore E, Turatti F, Luison E, Alberti P, Bagnoli M, Figini M, Mazzoni A, Raspagliesi F, Oggionni M, Pilotti S, Canevari S.
    Clin Cancer Res; 2004 Aug 01; 10(15):5202-14. PubMed ID: 15297424
    [Abstract] [Full Text] [Related]

  • 19. Akt-mediated cisplatin resistance in ovarian cancer: modulation of p53 action on caspase-dependent mitochondrial death pathway.
    Yang X, Fraser M, Moll UM, Basak A, Tsang BK.
    Cancer Res; 2006 Mar 15; 66(6):3126-36. PubMed ID: 16540663
    [Abstract] [Full Text] [Related]

  • 20. Downregulation of miR-130a contributes to cisplatin resistance in ovarian cancer cells by targeting X-linked inhibitor of apoptosis (XIAP) directly.
    Zhang X, Huang L, Zhao Y, Tan W.
    Acta Biochim Biophys Sin (Shanghai); 2013 Dec 15; 45(12):995-1001. PubMed ID: 24145606
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 32.